Quick Answer
Vanda Pharmaceuticals Inc. reported Common Stock Shares Outstanding of 59.10 million shares for the year ending 2025.
- Vanda Pharmaceuticals Inc. showed an increase of +1.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Vanda Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Vanda Pharmaceuticals Inc.'s Common Stock Shares Outstanding has grown by 110.8%.
- Historical annual values: Fiscal year 2025: 59.10 million shares | Fiscal year 2024: 58.31 million shares | Fiscal year 2023: 57.53 million shares | Fiscal year 2022: 56.78 million shares | Fiscal year 2021: 55.90 million shares | Fiscal year 2020: 54.87 million shares | Fiscal year 2019: 53.55 million shares | Fiscal year 2018: 52.48 million shares | Fiscal year 2017: 44.94 million shares | Fiscal year 2016: 44.00 million shares | Fiscal year 2015: 42.82 million shares | Fiscal year 2014: 41.49 million shares | Fiscal year 2013: 33.34 million shares | Fiscal year 2012: 28.24 million shares | Fiscal year 2011: 28.12 million shares | Fiscal year 2010: 28.04 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: